WallStreetZenWallStreetZen

NASDAQ: OABI
Omniab Inc Stock Forecast, Predictions & Price Target

Analyst price target for OABI

Based on 4 analysts offering 12 month price targets for Omniab Inc.
Min Forecast
$7.00+52.51%
Avg Forecast
$9.00+96.08%
Max Forecast
$11.00+139.65%

Should I buy or sell OABI stock?

Based on 4 analysts offering ratings for Omniab Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OABI stock forecasts and price targets.

OABI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-26
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2024-03-21

1 of 1

Forecast return on equity

Is OABI forecast to generate an efficient return?

Forecast return on assets

Is OABI forecast to generate an efficient return on assets?

OABI revenue forecast

What is OABI's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$32.8M-4.06%
Avg 2 year Forecast
$58.8M+72.05%
Avg 3 year Forecast
$84.2M+146.44%
OABI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OABI revenue growth forecast

How is OABI forecast to perform vs Biotechnology companies and vs the US market?
Company
35.15%
Industry
36.37%
Market
9.75%
OABI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OABI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OABI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OABI$4.59$9.00+96.08%Strong Buy
CELC$17.70$29.00+63.84%Strong Buy
ABUS$2.84$4.33+52.57%Strong Buy
AVBP$17.25$29.25+69.57%Strong Buy
ATXS$9.98$21.25+112.93%Strong Buy

Omniab Stock Forecast FAQ

Is Omniab Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: OABI) stock is to Strong Buy OABI stock.

Out of 4 analysts, 2 (50%) are recommending OABI as a Strong Buy, 2 (50%) are recommending OABI as a Buy, 0 (0%) are recommending OABI as a Hold, 0 (0%) are recommending OABI as a Sell, and 0 (0%) are recommending OABI as a Strong Sell.

If you're new to stock investing, here's how to buy Omniab stock.

What is OABI's revenue growth forecast for 2024-2026?

(NASDAQ: OABI) Omniab's forecast annual revenue growth rate of 35.15% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.37%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.75%.

Omniab's revenue in 2024 is $34,164,000.On average, 5 Wall Street analysts forecast OABI's revenue for 2024 to be $3,839,157,536, with the lowest OABI revenue forecast at $3,396,655,334, and the highest OABI revenue forecast at $4,556,203,189. On average, 5 Wall Street analysts forecast OABI's revenue for 2025 to be $6,884,668,984, with the lowest OABI revenue forecast at $5,504,924,162, and the highest OABI revenue forecast at $8,667,327,404.

In 2026, OABI is forecast to generate $9,861,193,191 in revenue, with the lowest revenue forecast at $7,660,043,408 and the highest revenue forecast at $11,712,604,600.

What is OABI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: OABI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is OABI's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OABI price target, the average OABI price target is $9.00, with the highest OABI stock price forecast at $11.00 and the lowest OABI stock price forecast at $7.00.

On average, Wall Street analysts predict that Omniab's share price could reach $9.00 by Mar 26, 2025. The average Omniab stock price prediction forecasts a potential upside of 96.08% from the current OABI share price of $4.59.

What is OABI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: OABI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.